Article
CDC42 Inhibition Suppresses Progression of Incipient Intestinal Tumors
11 Aug 2014
Abstract excerpt
Mutations in the APC or β-catenin genes are well-established initiators of colorectal cancer, yet modifiers that facilitate the survival and progression of nascent tumor cells are not well defined. Using genetic and pharmacologic approaches in mouse colorectal cancer and human colorectal cancer xenograft models, we show that incipient intestinal tumor cells activate CDC42, an APC-interacting small GTPase, as a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
